Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

HANNAH N KARSTEN

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical

NPI
1184264368
CMS profile
11277187
Location
ALBUQUERQUE, NM

General Payments · PY2023–2024

$968.85

  • Reported across 24 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$717.17

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $717.17 16

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
GlaxoSmithKline, LLC. $330.95 9
OptiNose US, Inc. $137.46 1
Acerta Pharma LLC $123.14 1
Regeneron Healthcare Solutions, Inc. $84.78 3
GENZYME CORPORATION $40.84 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2023 $251.68 8
PY2024 $717.17 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $123.14 12/10/2024 Food and Beverage Undisputed 01/23/2026 1104573472 CMS
GENZYME CORPORATION $22.89 06/20/2024 Food and Beverage Undisputed 01/23/2026 1139986536 CMS
GENZYME CORPORATION $17.95 09/19/2024 Food and Beverage Undisputed 01/23/2026 1139986554 CMS
GlaxoSmithKline, LLC. $20.18 01/31/2024 Food and Beverage Undisputed 01/23/2026 1116380582 CMS
GlaxoSmithKline, LLC. $20.80 02/29/2024 Food and Beverage Undisputed 01/23/2026 1116152272 CMS
GlaxoSmithKline, LLC. $123.14 03/07/2024 Food and Beverage Undisputed 01/23/2026 1116553977 CMS
GlaxoSmithKline, LLC. $21.66 04/08/2024 Food and Beverage Undisputed 01/23/2026 1116197221 CMS
GlaxoSmithKline, LLC. $22.18 06/10/2024 Food and Beverage Undisputed 01/23/2026 1116243812 CMS
GlaxoSmithKline, LLC. $7.36 07/29/2024 Food and Beverage Undisputed 01/23/2026 1116513275 CMS
GlaxoSmithKline, LLC. $86.47 08/08/2024 Food and Beverage Undisputed 01/23/2026 1115872985 CMS
GlaxoSmithKline, LLC. $5.14 09/16/2024 Food and Beverage Undisputed 01/23/2026 1116423983 CMS
GlaxoSmithKline, LLC. $24.02 10/07/2024 Food and Beverage Undisputed 01/23/2026 1116565864 CMS
Optinose US, Inc. $137.46 11/14/2024 Food and Beverage Undisputed 01/23/2026 1142183480 CMS
Regeneron Healthcare Solutions, Inc. $27.50 03/11/2024 Food and Beverage Undisputed 01/23/2026 1114323996 CMS
Regeneron Healthcare Solutions, Inc. $35.13 08/08/2024 Food and Beverage Undisputed 01/23/2026 1114323998 CMS
Regeneron Healthcare Solutions, Inc. $22.15 10/30/2024 Food and Beverage Undisputed 01/23/2026 1114324000 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2023, 2024
Source files
Dataset page · Bulk file · PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.